Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Advanced
Wish Lists Wish Lists
Wish Lists Wish Lists
Wish Lists
Cart Cart
Cart Cart
Cart
Sign in
Sign in
Contact us
Advanced
Homepage > Company > Media > Pharma News > 2018

Pharma News, 2018

A Decades-Old Asthma Drug Has Reversed Brain Damage From Dementia in Mice
A Decades-Old Asthma Drug Has Reversed Brain Damage From Dementia in Mice
Scientists have used a mice model to reverse some of the most severe damage done to the brain by dementia - and they did this with a surprisingly old medication typically used for asthma.
Aussie researchers develop new blood test to better predict heart attacks
Aussie researchers develop new blood test to better predict heart attacks
SYDNEY, June 14 (Xinhua) -- Australian researchers said on Thursday that they had developed a blood test that can better predict the long-term risk of heart attack or death in people with seve...
AbbVie Announces U.S. FDA Approval of VENCLEXTA® (venetoclax tablets) in Combination with Rituximab as a Fixed Duration Treatment for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients Who Have Received One Prior Therapy
AbbVie Announces U.S. FDA Approval of VENCLEXTA® (venetoclax tablets) in Combination with Rituximab as a Fixed Duration Treatment for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients Who Have Received One Prior Therapy
NORTH CHICAGO, Ill.
Ten Thousand Bursting Genes
Ten Thousand Bursting Genes
A breakthrough new technique enables scientists to image 10,421 genes at once within individual cells.
Galmed's 600 mg Aramchol™ Achieved a Regulatory Approvable Endpoint Showing NASH Resolution Without Worsening of Fibrosis, in NASH Patients, in the Global Phase 2b ARREST 52-Week Study
Galmed's 600 mg Aramchol™ Achieved a Regulatory Approvable Endpoint Showing NASH Resolution Without Worsening of Fibrosis, in NASH Patients, in the Global Phase 2b ARREST 52-Week Study
TEL AVIV, Israel, June 12, 2018 /PRNewswire/ --    Statistically significant reduction in liver fat was demonstrated by Magnetic Resonance Spectroscopy (MRS) in patients...
Update on Phase III clinical trials of lanabecestat for Alzheimer’s disease
Update on Phase III clinical trials of lanabecestat for Alzheimer’s disease
AstraZeneca and Eli Lilly and Company (Lilly) are discontinuing the global Phase III clinical trials of lanabecestat, an oral beta secretase cleaving enzyme (BACE) inhibitor, for the t...
Vertex presents real-world data highlighting benefit of CF drug Kalydeco
Vertex presents real-world data highlighting benefit of CF drug Kalydeco
Vertex has presented long-term, observational data highlighting the benefit of Kalydeco in patients with cystic fibrosis.
Pfizer files PARP inhibitor for breast cancer in US, EU
Pfizer files PARP inhibitor for breast cancer in US, EU
Regulators on both sides of the Atlantic have accepted for review Pfizer’s PARP inhibitor talazoparib as a treatment for women with a hereditary BRCA mutation.
Blood test for pregnant women can predict premature birth
Blood test for pregnant women can predict premature birth
A new blood test for pregnant women detects with 75-80 percent accuracy whether their pregnancies will end in premature birth.
A trembling cursor or struggling to scroll online could be early signs of Parkinson's or Alzheimer's, reveal scientists Microsoft and Duke University analysed online activity of 31 million Americans
A trembling cursor or struggling to scroll online could be early signs of Parkinson's or Alzheimer's, reveal scientists Microsoft and Duke University analysed online activity of 31 million Americans
A shaking mouse cursor, slow scrolling speed and repetitive online searches could allow computers to spot early signs of Parkinson's or Alzheimer's disease.
In Missouri, J&J faces biggest trial yet alleging talc caused cancer
In Missouri, J&J faces biggest trial yet alleging talc caused cancer
NEW YORK (Reuters) - A lawsuit by 22 ovarian cancer patients against Johnson & Johnson went to trial on Wednesday in Missouri state court, marking the largest case the company has faced ov...
FDA warns websites to stop illegal online opioid sales
FDA warns websites to stop illegal online opioid sales
"The public needs to know that no one is authorized to sell or distribute opioids via the Internet in the U.
0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds